Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report.
The concomitant occurrence of pregnancy and chronic myeloid leukemia is uncommon. The use of hydroxyurea in chronic myeloid leukemia during pregnancy is unknown. We report on a patient with chronic myeloid leukemia in whom hydroxyurea was used during pregnancy with a successful outcome for both mother and fetus.
Patel
M
M
Department of Medicine, University of the Witwatersrand, Baragwanath Hospital, Johannesburg, Republic of South Africa.
Dukes
I A
IA
Hull
J C
JC
D000328:Adult; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*
D006918:Hydroxyurea